Related Experiment Video
Updated: Aug 23, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Reference Intervals for Coagulation Parameters in Developmental Hemostasis from Infancy to Adolescence.
Giovina Di Felice1, Matteo Vidali2, Gelsomina Parisi1
1Clinical Laboratory Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Establishing age and sex-specific reference intervals for pediatric coagulation tests is crucial. This study provides these vital reference ranges for children aged 0-16 years to prevent misdiagnosis and improve patient care.
Area of Science:
- Pediatric Hematology
- Clinical Coagulation
- Laboratory Medicine
Background:
- Pediatric coagulation assays require distinct reference intervals compared to adults.
- Current reference ranges may not accurately reflect the physiological differences in children.
- Accurate reference intervals are essential for diagnosing and managing bleeding and thrombotic disorders in pediatric populations.
Purpose of the Study:
- To establish age- and sex-dependent reference intervals for a comprehensive panel of coagulation assays in healthy children.
- To cover a wide pediatric age range from neonates (0 days) to adolescents (16 years).
- To provide data supporting the use of pediatric-specific reference ranges in clinical practice.
Main Methods:
- Coagulation assays including PT, aPTT, Fibrinogen, Antithrombin, Protein C, Protein S, Thrombin time, D-Dimer, vWF antigen, Lupus anticoagulant, pathway factors, and APC resistance were performed.
- The STA-R Max2 analyzer was utilized for all tested coagulation parameters.
- The Harrell-Davis bootstrap method was employed to establish 95% reference intervals, with 90% confidence intervals calculated using the bootstrap percentile method.
Main Results:
- Data were collected from 1280 healthy children (671 males, 609 females) across five age groups: 0-15 days, 15-30 days, 1-6 months, 6-12 months, and 1-16 years.
- Age and sex-specific 95% reference intervals were successfully determined for all evaluated coagulation assays.
- Significant variations in coagulation parameters were observed across different pediatric age strata.
Conclusions:
- The study confirms the necessity of distinct reference intervals for pediatric coagulation testing.
- Utilizing adult reference intervals for children can lead to misdiagnosis of coagulation disorders.
- Implementing age- and sex-specific reference ranges is critical for accurate diagnosis, appropriate treatment, and improved patient outcomes in pediatrics.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins